#MSToronto2026 Pre-Day is underway! Opening the third edition of Pre-Day, @ECTRIMS President Professor Bruno Stankoff highlighted the rapid progress taking place across the field and the importance of bringing experts together to address emerging scientific and clinical challenges. Today's programme features five sessions exploring: • Disease Mechanisms • Diagnostic Challenges • Prognosis and Outcomes Informed by Imaging and Fluid Biomarkers • Clinical Course and Outcomes • Treatment Approaches As our understanding of neuroimmunological diseases advances, so too does the need to explore where these conditions converge, where they differ and what these discoveries mean for diagnosis and treatment. Bringing together perspectives on MS, MOGAD, NMOSD, autoimmune encephalitis and other neuroinflammatory conditions, Pre-Day creates an important opportunity to exchange knowledge, strengthen collaboration and advance our collective understanding of neuroimmunology. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞 ➡️ bit.ly/4yiNJd5 @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #MSToronto2026 #MultipleSclerosis #Neurology #MSResearch

🌍 Don’t forget to join us at Patient Community Day on 23 Oct at 15:00 EDT. Engage with global experts, share your questions, and be part of the conversation driving MS research forward. 𝐒𝐢𝐠𝐧 𝐮𝐩 ➡️ bit.ly/44elQGb #ECTRIMS4me #PatientCommunityDay #MS #NMOSD #MOGAD

🔍 𝐖𝐡𝐚𝐭 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐫𝐞𝐦𝐚𝐢𝐧 𝐢𝐧 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐧𝐠 𝐌𝐎𝐆𝐀𝐃? Our latest Spotlight, 𝘔𝘖𝘎𝘈𝘋: 𝘌𝘮𝘦𝘳𝘨𝘪𝘯𝘨 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴 𝘢𝘯𝘥 𝘌𝘷𝘰𝘭𝘷𝘪𝘯𝘨 𝘊𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦𝘴, explores the latest developments in MOGAD diagnosis, biomarkers, and therapeutic approaches. Read the Spotlight here: ectrims.eu/mogad-emerging-in… "While the criteria are a big step forward, obstacles remain in differentiating MOGAD from MS, which is crucial given the differences in treatment," says Professor Anne-Katrin Pröbstel of Universitätsklinikum Bonn and Universitätsspital Basel (USB). "A key unresolved question in MOGAD management is: how long do we treat people for, both after an initial attack and in those who experience relapses?" adds Dr. Wei Yeh of Monash University in Melbourne. The ECTRIMS Spotlight Series is curated and authored by our Scientific Content Writer, Stefania de Vito. #MultipleSclerosis #MOGAD #MSResearch #Neurology #MSSpotlight #Neuroimmunology #ECTRIMS

#Women with #MS face unique challenges, such as #reproductive issues and #menopause. Read the recap of our recent 3webinar feat. experts from @ClevelandClinic @cemcat_em & @DalhousieU as they discuss where research should focus its efforts first ➡️ bit.ly/48Sulsk

Researchers looking for the causes of #MS should factor in the prodromal phase, says Prof. Helen Tremlett of @UBC. In our latest #podcast, Brett Drummond of @MSTranslate explores what the MS prodrome means for diagnosis & treatment. Listen now! 👉 bit.ly/4hvgUCy

🚀 Happening today! It's not too late to join our free #webinar focusing on the unmet needs of women with #MS at 18:30-19:30 CET. Featuring experts from @cemcat_em, @ClevelandClinic & @DalhousieU. Register here! ➡️ bit.ly/48HlVUR